Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Edge-to-edge MItral vaLve Repair in Patients With Severe mitraL rEgurgitatioN aNd cardIac ATTR amyLoidosis

NCT06075823 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06075823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06075823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Edge-to-edge MItral vaLve Repair in Patients With Severe mitraL rEgurgitatioN aNd cardIac ATTR amyLoidosis
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2024
Completion date
December 12, 2028
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

attr-cardiomyopathy, edge-to-edge mitral valve repair, mitral regurgitation